Statements regarding this peptide blend and related scientific findings have not been evaluated by regulatory authorities and should not be interpreted as medical advice, therapeutic claims, or health recommendations
[DOI] [PMC free article] [PubMed] [Google Scholar] Zhang L, Huang J, Su S, et al
This study had sham as control group
At this point, many of us have heard about GLP-1 agonist (glucagon-like peptide-1) medications and their effectiveness in managing type 2 diabetes and aiding weight loss
deficiencies of vitamin B12, folate or niacin, and infective causes including cryptococcal meningitis, HIV, Lyme disease, progressive multifocal leukoencephalopathy, subacute sclerosing panencephalitis, syphilis and Whipple's disease